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The nuclear factor-κB (NF-κB) family of transcription factors can directly or indirectly reg-
ulate many important areas of biology, including immunity, inflammation and cell survival.
One intriguing aspect of NF-κB crosstalk with other cell signalling pathways is its regulation
of mitochondrial biology, including biogenesis, metabolism and apoptosis. In addition to
regulating the expression of mitochondrial genes encoded in the nucleus, NF-κB signalling
components are also found within mitochondria themselves and associated with mitochon-
drial DNA. However, complete biochemical analysis of mitochondrial and sub-mitochondrial
localisation of all NF-κB subunits has not been undertaken. Here, we show that only the
RelA NF-κB subunit and its inhibitor IκBα reside within mitochondria, whilst p50 is found in
the endoplasmic reticulum (ER). Fractionation of mitochondria revealed that only RelA was
found in the mitoplast, the location of the mtDNA. We demonstrate that hypoxia leads to a
very rapid but transient accumulation of RelA and IκBα in mitochondria. This effect required
reactive oxygen species (ROS) but was not dependent on the hypoxia sensing transcription
factor subunit HIF1α or intracellular Ca2+ release. We also observed rapid mitochondrial lo-
calisation of transcription factor STAT3 following hypoxia. Inhibition of STAT3 blocked RelA
and IκBα mitochondrial localisation revealing a previously unknown aspect of crosstalk be-
tween these key cellular regulators.
Introduction
The nuclear factor-κB (NF-κB) family of transcription factors regulate the expression of a vast array of
genes in response to extra- and intracellular stimuli by binding to κB DNA responsive elements within
their promoters [1]. An important regulator of immunity, inflammation, development, cell division and
survival, NF-κB also participates inmany additional processes via crosstalkwith other signalling pathways
[2]. Aberrant NF-κB activation is therefore associated with many diseases, including cancer, with tumour
cells often exhibiting constitutively active NF-κB [3].
Mammalian NF-κB consists of five subunits, RelA (p65), RelB, c-Rel, p100/p52 and p105/p50, all of
which contain the RELHomologyDomain (RHD) thatmediatesDNAbinding and dimer formation [4,5].
The C-termini of RelA, RelB and c-Rel also contain transactivation domains, essential for controlling the
expression of target genes [6,7]. NF-κB subunits form homo or heterodimers, held in the cytoplasm in
an inactivated state through interactions masking their nuclear localisation sequences. RelA and c-Rel
are inactivated by the ankyrin repeat containing Inhibitor of NF-κB (IκB) proteins such as IκBα [8]. The
NF-κB subunit precursors p100 and p105 have their ownC-terminal ankyrin repeat domains and can also
function as inhibitors [9]. Activation of NF-κB therefore requires the removal of these inhibitors, either
via degradation of the IκB proteins or processing of p100 and p105 to the shorter forms p52 and p50, re-
spectively [10–12]. IκBs are phosphorylated and targeted for proteasomal degradation via the IκB kinase
(IKK) complex, consisting of IKKα, IKKβ and NEMO [13]. This allows the nuclear localisation of the ac-
tive NF-κB complexes, followed by target gene promoter binding and transcriptional regulation. It is now
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emerging that apart from their functions in NF-κB signalling, components of this pathway also play other indepen-
dent roles [14,15].
Mitochondria are double membrane organelles containing their own genetic material encoded on circular DNA
molecules (mtDNA) that are essential for energy, metabolite and reactive oxygen species (ROS) production, as well
as calcium storage and apoptosis [16,17]. Mitochondrial dysfunction can lead to many diseases and is a contributing
factor to ageing and cancer development. NF-κB signalling can directly regulate at least three aspects ofmitochondrial
biology: biogenesis by controlling the levels of dynamin-like protein Opa1 required for mitochondrial fusion [18];
metabolism by regulating the expression of a number of mitochondrial genes encoded in the nucleus as well as the
mtDNA [19–22]; and apoptosis [19,21–24]. In most cases, mitochondrial changes induced by NF-κB culminate in
cell survival. Changes inmitochondrial metabolism throughNF-κB activity could also contribute towards its tumour
promotor function via suppression of p53 signalling [19,23].
RelA, p50 and IκBα have all been reported to reside within the mitochondria of cancer cell lines as well as in
tissues [20–27], suggesting that someNF-κB effects onmitochondria might be direct. Mitochondrial RelA was found
to associatewith theD-loop region ofmtDNAand alter cytochrome b (CYTB) expression but this was still observed in
a DNA bindingmutant form of RelA, suggesting it is likely to be an indirect interaction [20,21]. Additionally, analysis
of publically available ENCODE chromatin immunoprecipitation (ChIP)-seq datasets of nuclear transcription factor
occupancy on mtDNA also suggests that NF-κB does not associate directly with the mitochondrial genome [28].
Therefore, it is likely that mitochondrial NF-κB does not have a classical transcriptional role, but rather, alters gene
expression of mtDNA encoded genes as a co-factor or through alternative mechanisms.
RelA can interact with the mitochondrial chaperone mortalin, in a manner antagonised by the p53 tumour sup-
pressor, leading to increased O2 consumption and ATP production [23]. Mitochondrial RelA levels also increase
during apoptosis driven by ANT1 overexpression and LPS stimulation in cell lines, as well as in rat retina cells after
exposure to very bright light [22,26]. Fas-induced apoptosis, on the other hand, reduced mitochondrial RelA and
IκBα levels [25]. In all these cases, RelA was required for cell survival, indicating that mitochondrial RelA may play a
role in preventing apoptosis. However, IκBα has been reported to be mostly associated with the outer mitochondrial
membrane (OMM) with only a small fraction residing inside mitochondria [25,27]. Activation of NF-κB signalling
by TNFα or Fas decreases mitochondrial IκBα and plays an important role in preventing apoptosis, independently
of its function during NF-κB signalling [20,25]. OMM-associated IκBαmediates the interaction of VDAC and HKII
during apoptosis and is necessary for survival [27]. These anti-apoptotic functions of mitochondrial IκBα contribute
to tumour survival after doxorubicin treatment [27]. Although a mitochondrial form of p50 has been reported to
have DNA binding activity, no functional data are currently available regarding a mitochondrial role for this NF-κB
subunit [20,21].
Given these important functions of RelA and IκBα in mitochondrial metabolism and apoptosis, we decided to
perform a detailed analysis of both the presence and sub-mitochondrial localisation of all NF-κB subunits. We dis-
covered that only RelA and IκBα were consistently found inside mitochondria, whilst p50 resided in the ER. RelA
mitochondrial localisation depended on the OMM translocase TOM40 and the mitochondrial chaperone mortalin.
Additionally, we identified hypoxia as a novel stimulus causing a transient increase in mitochondrial RelA and IκBα,
independently of the main hypoxia transcription factor subunit HIF1α and calcium signalling. Instead, reactive oxy-
gen species (ROS) production drives RelA, IκBα as well as STAT3 mitochondrial localisation. We also report that
localisation of RelA and IκBα to hypoxic mitochondria is dependent on STAT3 signalling, revealing a new and un-
expected aspect of crosstalk between these pathways.
Materials and methods
Cell culture
Human Embryonic Kidney 293 (HEK293); breast cancer MCF7 and MDA-MB-231; and osteosarcoma U2OS cell
lines were maintained in DMEM supplemented with 10% FBS (Thermo Fisher), 2 mM L-glutamine (SLS) and 50 U
Penicillin/Streptomycin (SLS). Prostate cancer PC3 cells were cultured in RPMI with 25 mM HEPES supplemented
with 10% FBS (Thermo Fisher) and 2 mM L-glutamine (SLS), whilst primary normal human juvenile dermal fibrob-
lasts (Promocell) were maintained in Fibroblast growth media supplemented with 2% supplement mix (Promocell)
and 1% Penicillin/Streptomycin/Fungizone Solution (Promocell).
Treatments
In hypoxia experiments, cells were incubated for the indicated times at 1% O2 in an in vivo 400 hypoxia work station
(Ruskin). DMOG (Sigma); Thaspsigargin (Enzo); TPCA1 (Stratech) and STATTIC (Sigma) were dissolved in DMSO.
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N-acetyl-L-cysteine (SLS)was diluted inwater and adjusted to pH7.5. Cellswere treated accordingly at concentrations
and times indicated in figure legends.
Mitochondria isolation by differential centrifugation
Cells were homogenised with a 7 ml Dounce homogenizer in homogenisation buffer (0.6 M D-mannitol, 5 mM Tris,
pH 7.6; 1 mM EGTA, 0.1% BSA, 1μg/ml Leupeptin, Pepstatin A and Aprotenin and 1 mM PMSF) and centrifuged
at 400 × g for 10 min at 4◦C to remove cell debris. Cytoplasmic and crude mitochondrial fractions were obtained by
centrifugation of the supernatant at 11,000 × g for 10 min at 4◦C. Protein concentration was measured by Bradford
(BioRad) and the mitochondrial pellets and the cytosolic fraction were treated with 10 ng Proteinase K per μg of
protein for 30 min on ice. The Proteinase K treated mitochondria were washed in homogenisation buffer and the
concentrations of cytosolic and mitochondrial protein were measured by Bradford assay (Biorad), to allow equal
loading for analysis by SDS/PAGE and immunoblotting.
Purification of mitochondria-associated ER
Crude mitochondria were prepared by differential centrifugation and laid on a 15%/17.5%/20% OptiPrep Density
Gradient Medium (Sigma). The mitochondria and ER fractions were separated at 100,000× gwith an Optima L-100
XP ultracentrifuge (Beckman Coulter) equipped with a SW40Ti rotor for 2 h at 4◦C. The purified ER was harvested
from the 20% layer and half was treated with 10 ng Proteinase K per μg of protein for 30 min on ice. Equal amounts
of protein were further analysed by immunoblotting.
Mitochondrial sub-fractionation
Crude mitochondria were prepared by differential centrifugation, incubated on a tube rotator with 0.2U DNAse per
mg of mitochondria for 15 min at room temperature and sub-fractionated by swelling with 1 mMEDTA/10mMTris,
pH 7.4 on a tube rotator at 4◦C. The remaining mitoplast containing only the inner mitochondrial membrane and
the enclosed matrix was additionally treated with 5 ng proteinase K/μg of protein for 30 min on ice. Equal amount of
protein was further analysed by immunoblotting.
siRNA knock down
U2OS cells were seeded at a density of 400,000 cells/plate in 10 cm2 dishes and transfected in OptiMem (Ther-
moFisher) with 5 nM siRNA pools or single siRNAs with 5 μl INTERFERin (Polyplus Transfection) transfection
reagent the following day. After 48 h, the cells were split into 15 cm2 dishes and transfected again with 7.5 nM
siRNA pools with 7.5 μl INTERFERin transfection reagent in OptiMem. The cells were harvested and mitochon-
dria isolated 48 h later by differential centrifugation. Protein levels in the mitochondrial and cytosolic fractions were
assessed by Bradford assay (BioRad) and mitochondria were further treated with 10 ng Proteinase K per μg of pro-
tein for 30 min on ice. The siRNA used were as follows: Scramble 5′ CAGUCGCGUUUGCGACUGG; RelA siRNA
1 5′ GCUGAUGUGCACCGACAAG; RelA siRNA 2 5′ GCCCUAUCCCUUUACGUCA; IκBα 5′ ACACUCAGCU-
CAUAAUA;TOM40 siRNA1ACUGAACAACUGGUUGG;TOM40 siRNA2CCCUCUGUAUGAAAUAG;TOM40
siRNA 3 GAAGAUGACUAUUUCAU; TIM50 siRNA 1 5′ AAUGUUGGCUUCUAACUAA; TIM50 siRNA 2 5′
GGUCUGUACUGUCCAGUAC; Mortalin 5′ CGAGUUGAAGCAGUUAAUA.
Immunoblotting
Protein quantity was measured with Bradford reagent (BioRad) and prepared in SDS loading dye. For detecting
HIF1α, a sample of the cells was harvested in 8 M Urea, sonicated and the protein quantified with the BCA as-
say (ThermoFisher). Between 5 and 10 μg of protein per well was loaded on SDS/PAGE (BioRad), separated and
transferred with the Trans Blot Turbo semi dry system (BioRad) to PVDF (Millipore) membranes. The following an-
tibodies were used for the present study at a dilution 1:1000: RelA C-terminal (sc-372, SantaCruz); RelA N-terminal
(#4764, Cell Signalling); IκBα (#9242, Cell Signalling); p105/p50 (#3035, Cell Signalling); p100/p52 (#4882, Cell
Signalling); RelB (#4954, Cell Signalling); c-Rel (#4727, Cell Signalling); α-tubulin (#2144, Cell Signalling); VDAC
(#4866, Cell Signalling); protein disulphide isomerase (PDI) (sc-20132, Santa Cruz); TOM40 (sc-11414, Cell Sig-
nalling); AIF (sc-13116, Cell Signalling); TIM50 (SBS0666, Source BioSciense);Mortalin (MA3-028; Thermo Fisher);
calnexin (#2433, Cell Signalling); HIF1α (610958, BD Transduction Laboratories); STAT3 (#9139, Cell Signalling).
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Immunofluorescence of saponin permeabilised cells
U2OS cells were grown on cover slips and exposed to hypoxia as indicated in figure legends. The cells were perme-
abilised with Solution A (7.23 mMK2EGTA, 2.77 mMCaK2EGTA, 60mMMES, 20mM taurine, 3 mMK2HPO4, 0.5
mM DTT, 81 mM CH3KO3S, pH 7.1) supplemented with 2.88 mg/ml MgATP and 70 μg/ml saponin for 10 min on
ice according to [29]. After three washes with Solution A containing MgATP, cells were fixed in 3.7% Formaldehyde
for 10 min, permeabilised with 1% Triton-X/0.05% Tween 20 for 15 min, washed in PBS and blocked for 30 min in
10% BSA in PBS/0.05% Tween 20. Slides were stained for 1 h with a 1:200 dilution of RelA sc-372 antibody (Santa
Cruz) in 1% BSA/PBS/0.05%Tween20, washed in PBS and stained in the dark with a 1:500 dilution of goat anti-rabbit
IgG DyLight 550 (Thermo Fisher) in 1% BSA/PBS/0.05% Tween20 for 30 min. After three more washes with PBS,
slides were mounted with ProLong Gold mounting media containing DAPI (Invitrogen) and imaged with a Nikon
A1R inverted confocal microscope.
Results
Only RelA from the NF-κB family of transcription factors, as well as IκBα
reside inside mitochondria
Several studies have demonstrated that members of the NF-κB signalling pathway can be present within mitochon-
drial protein extracts, including RelA, p50, IκBα, IKKα, IKKβ and IKKγ, where they are thought to control apopto-
sis and mitochondrial metabolism [20,21,23,26,27]. However, a full investigation of the mitochondrial presence of all
NF-κB subunits has not been undertaken. Moreover, mitochondria are closely associated with the ER [30] and some
protocols are not able to distinguish between localisation in different compartments of the mitochondria or potential
ER contamination.
To investigate the mitochondrial localisation of NF-κB subunits, crude mitochondria were purified by differential
centrifugation of cellular homogenates containing intact organelles from p53 wild-type HEK293 and p53 mutant
MDA-MB-231 cells to account for the known inhibitory effects of p53 expression on mitochondrial NF-κB [19,23].
Mitochondria isolated by this method, confirmed by the presence of the mitochondrial outer membrane protein
VDAC, were free of cytosolic contamination, as shown by the lack of tubulin (Figure 1A). Examination of all NF-κB
subunits in MDA-MB-321 and HEK293 cells corroborated previous findings that RelA, IκBα and p50 are associated
withmitochondria [20,21,23,26,27]. Additionally, p105, p100/p52 and c-Rel but not RelBwere also associatedwith the
organelle (Figure 1A). However, only RelA and IκBα in both cell lines and p50 in MDA-MB-231 cells were resistant
to proteinase K digestion, utilised to remove proteins unshielded from themitochondrial membranes. This suggested
that whilst p50 might only be associated with mitochondria in cells with mutant p53, RelA and IκBα can localise to
mitochondria independently of p53 status. (Figure 1A). InHEK293 cell, we also noticed thatwith theN-terminal RelA
antibody we detected a lower mobility band present only in the mitochondria that was also proteinase K resistant.
However, RelA siRNA knock down indicated that this band was non-specific (data not shown). This data indicates
that even though p105, p100/p52 and c-Relmight exist in proximity tomitochondria, they are unlikely to reside inside
the organelle.
Further analysis demonstrated that mitochondria isolated through differential centrifugation also contained a pro-
teinase K resistant fraction of the ER, confirmed by the presence of the ER lumen chaperone PDI (Figure 1B). Al-
though this observation is not unusual, given the physical and functional interactions between these organelles [30],
it was essential to discount the possibility of ER localisation of RelA, IκBα or p50. Crude ER/mitochondria prepara-
tions fromMDA-MB-231 cells were, therefore, further separated on a Percol gradient to obtain a purified ER fraction.
Proteinase K treatment of this fraction revealed that although RelA and IκBα were degraded, p50 remained intact in
the ER, suggesting that its apparent localisation in mitochondrial extracts in MDA-MB-231 cells (Figure 1A) might
originate from contaminating ER (Figure 1C). We therefore only focused on RelA and IκBα in subsequent experi-
ments.
Next, mitochondria were subjected to further fractionation by swelling and removal of the OMM to obtain the mi-
toplast, thematrix enveloped by the innermitochondrial membrane (IMM) that contains themitochondrial genome.
Interestingly, RelA localised partially to the proteinase K-treated mitoplast whilst IκBα did not (Figure 1D).
To confirm antibody specificity, we performed RelA or IκBα siRNA knockdown in highly transfectable
MDA-MB-231 cells and observed reduced signals for both proteins in mitochondria (Figure 1E). RelA knockdown
also reduced the levels of cytosolic IκBα, although this may reflect a reduction in IκBα transcription, which is under
the control of RelA [31]. The loss of mitochondrial RelA following IκBα siRNA knockdown was unexpected and
could be due to IκBα acting as a chaperone to RelA.
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Figure 1. RelA and IκBα reside in mitochondria
Protein levels from the indicated sub-cellular fractions were analysed by immunoblotting. Mitochondrial and cytosolic extracts were
prepared from MDA-MB-231 (A) and HEK293 (A, B) cells by differential centrifugation. Both fractions were treated with 10 ng/μg of
protein with proteinase K for 30 min on ice. (C) The ER from MDA-MB-231 cells was separated from crude mitochondrial extracts
on a 15%/17.5%/20% OptiPrep gradient. Pure ER was collected in the 20% fraction and treated with 10 ng/μg of protein with
proteinase K for 30 min on ice. (D) Mitochondria from HEK293 cells were treated with 0.2 U DNAse per mg of mitochondria for 15
min at room temperature and sub-fractionated by swelling with 10 mM Tris, pH 7.4. The remaining mitoplast containing only the
inner mitochondrial membrane and the enclosed matrix was additionally treated with 5 ng/μg of protein with proteinase K from 30
min on ice. (E) RelA and IκBα were knocked down with siRNA in MDA-MB-231 cells and proteinase K-treated mitochondria were
prepared as in A. Data are representative of a minimum of two independent experiments.
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Figure 2. TOM40 and mortalin are required for the mitochondrial import of RelA
Mitochondrial and cytosolic extracts were prepared by differential centrifugation from U2OS cells, where TOM40 (A), TIM50 (B) or
mortalin (C) were knocked down with siRNA. The mitochondrial fractions were treated with 10 ng/μg of protein with proteinase K for
30 min on ice. Protein levels in each fraction were analysed by immunoblotting as indicated. Data are representative of a minimum
of two independent experiments.
TOM40 and mortalin are required for RelA mitochondrial localisation
Most mitochondrial proteins are nuclear encoded and need to be imported into mitochondria post-translation. The
classical pathway for mitochondrial import is through the translocase of the outer membrane (TOM) followed by
the translocase of the inner membrane (TIM) [32]. These are large multiprotein complexes forming pores through
the mitochondrial membranes to deliver proteins into the intermembrane space and matrix by using ATP and the
mitochondrial membrane potential.
To identify which translocase is involved in RelA localisation into mitochondria we used siRNA to knockdown
subunits of both translocases in highly transfectable U2OS cells and obtained proteinase K treated-mitochondria by
differential centrifugation. RelA mitochondrial import depended on TOM40, a component of the TOM complex
that forms a barrel traversing the outer mitochondrial membrane (Figure 2A). However, TIM50, one of three integral
membrane proteins of the TIM translocase, was not involved in intrinsic RelAmitochondrial localisation (Figure 2B),
although this experiment did not examine localisation to the mitoplast.
Our previous findings identified the matrix protein mortalin as a RelA interactor, crucial for its mitochondrial
import [23]. Indeed, mortalin knockdown reduced the mitochondrial levels of RelA, confirming that it is needed for
RelA mitochondrial localisation (Figure 2C).
Hypoxia triggers rapid and transient mitochondrial translocation of RelA
and IκBα
We were curious about the functional significance of RelA and IκBα localisation to mitochondria, specifically in the
context of cellular signalling known to regulate their activity. A number of nuclear transcription factors have been
found to translocate to mitochondria during hypoxia [33–35]. Therefore, we asked if RelA and IκBα could also do so
by exposing cells to 1%O2 and preparing proteinase K-treatedmitochondria. Indeed, we observed that both RelA and
IκBα translocated to mitochondria within minutes of cells being subjected to hypoxia, with levels decreasing after 1
h (Figure 3A). This was further confirmed by immunofluorescence (Figure 3B,C). Due to the high cytosolic presence
of RelA, normoxic and hypoxic U2OS cells were first permeabilised with saponin and the cytosol was washed out,
leaving only organelle associated RelA. Analysis of confocal images revealed that RelA colocalised withmitochondria
significantly more during hypoxia (Figure 3B,C). It is, therefore, likely that RelA and IκBα are implicated in the early
stages of hypoxia, rather than during later stages of adaptation via transcription.
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Figure 3. Hypoxia induces a transient RelA and IκBα translocation into mitochondria
(A) Cytosolic and mitochondrial extracts were prepared by differential centrifugation from HEK293 and MCF7 cells cultured for the
indicated times at 1% O2. Protein levels in each fraction were assessed by immunoblotting as indicated. Data are representative of
a minimum of two independent experiments. (B) U2OS cells were grown on cover slips, mitochondria were stained with MitoTracker
DeepRed FM (Invitrogen), exposed to 1% O2 for 30 min, cytosolic RelA was removed by permeabilisation with 70 μg/ml saponin
on ice under hypoxia and fixed with formaldehyde. Organelle-associated RelA was stained with sc-372 primary antibody (Santa
Cruz) and goat anti-rabbit IgG DyLight 550 (Thermo Fisher). Confocal Z stack images were obtained with a Nikon A1R inverted
microscope. (C) A total of eight normoxic and eight hypoxic cells from three images each were analysed with the Huygens Colocal-
ization Analyser [64]. Regions of interest that include the mitochondria but exclude the nucleus in individual cells were measured
and the Manders’ Overlap Coefficient was calculated for each cell. The values depicted in blue on the graph correspond to the
cells shown in (B). The error bars represent standard deviation and statistical analysis was performed in Prism Software with a
two-tailed, unpaired t-test.
Elevated mitochondrial RelA and IκBα levels during hypoxia are ROS
dependent
Hypoxia activates NF-κB via IKK, independently of signalling through the oxygen sensing hypoxia-inducible tran-
scription factor HIF1α, although in hypoxia activation does not involve degradation of IκBα [36,37]. However, lack
of oxygen in cells and tissues leads to several additional rapid physiological changes, occurring within minutes of
exposure to hypoxia, such as a burst of mitochondrial ROS and superoxide levels [38,39], an increase in intracellular
© 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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Ca2+ levels [40,41] and accumulation of HIF1α [42]. ROS and superoxide generation during hypoxia mainly origi-
nates from the Q cycle in complex III of the mitochondrial electron transport chain [43,44] and is accumulated in the
first 30 min after which levels return to basal level [39,45].
To determine if any of these events are involved in mitochondrial RelA and IκBα localisation during hypoxia, we
first treated MDA-MB-231 cells with the hypoxia mimetic DMOG, which inhibits the PHD enzymes responsible for
HIF1α hydroxylation and proteolytic degradation, leading to accumulation of HIF1α without lowering O2 levels.
DMOG treatment did not altermitochondrial RelAor IκBα levels (Figure 4A). This findingwas reinforced by using
a chemical inhibitor of HIF1α translation, thapsigargin that blocks the production of HIF1α protein by preventing
the association of the RNA binding protein YB1 with the 5′UTR of HIF1αmRNA [46]. Thapsigargin is also known
as a sarco/endoplasmic reticulum Ca2+−ATPase (SERCA) inhibitor that depletes the ER calcium stores and results
in accumulation of intracellular Ca2+, another event associated with early hypoxia. Cells treated with thapsigargin
showed no changes to RelA and IκBαmitochondrial translocation either with or without hypoxia exposure (Figure
4B). Taken together these findings suggest that HIF1α hydroxylation and accumulation, as well as Ca2+ release do not
appear to trigger RelA and IκBαmitochondrial translocation (Figure 4A,B). Instead, cells treatedwith the antioxidant
N-acetyl-L-cysteine (NAC) prevented the mitochondrial translocation of RelA and IκBα during hypoxia, suggesting
mitochondrial ROS production is required for mitochondrial RelA and IκBα accumulation (Figure 4C).
STAT3 signalling is required for RelA and IκBα mitochondrial
accumulation during hypoxia
Hypoxia can activate NF-κB within 5 min of exposure via IKKβ [36]. These kinetics are strikingly similar to our
observation of RelA and IκBαmitochondrial translocation within 5 min of hypoxia (Figure 3A). To establish if IKK
signalling was needed for mitochondrial translocation of RelA and IκBα, we utilised the ATP competitive IKKβ
inhibitor TPCA1. TPCA1 is also known to inhibit STAT3, a nuclear transcription factor that translocates to mito-
chondria during hypoxia, by binding to its SH2 dimerisation domain and preventing phosphorylation of adjacent
sites required for activity [33,47]. To address this off target effect, we obtained proteinase K-treated mitochondria
from the STAT3 negative cell line PC3 [48]. TPCA1 reduced mitochondrial RelA and IκBα levels in PC3 cells during
hypoxia, indicating that active NF-κB signalling is required for their mitochondrial accumulation (Figure 5A). We
also observed an increase of RelA and IκBα in normoxia following TPCA1 treatment, which could be due to off target
effects.
To further delineate the pathway required for RelA and IκBαmitochondrial accumulation, we utilised STATTIC,
an irreversible inhibitor of STAT3. Similarly to TPCA1, STATTIC also inhibits the SH2 dimerisation domain and
adjacent phosphorylation sites of STAT3, resulting in lack of DNA binding and loss of Tyr705 and Ser727 phosphory-
lation [49,50]. Interestingly, STAT3 positiveMCF7 cells treated with this inhibitor accumulated less STAT3, RelA and
IκBα intomitochondria during hypoxia, suggesting that active STAT3 can also regulate themitochondrial association
of these factors (Figure 5B). Moreover, NAC also reduced mitochondrial STAT3 levels in cells undergoing hypoxia,
implicating ROS in mitochondrial STAT3 signalling (Figure 5C). This is consistent with the role of mitochondria
targeted STAT3 in decreasing ROS production by the electron transport chain of ischemic mouse hearts [33]. It is
therefore likely that hypoxia-associated ROS production acts as a signal to rapidly recruit STAT3, RelA and IκBα to
mitochondria.
Discussion
In the present study, we established that of the NF-κB subunits, only RelA together with its inhibitor IκBα, are con-
sistently found inside the mitochondria of unstimulated cancer cells (Figure 1A,C). Moreover, we investigated the
mitochondrial import route for RelA (Figure 2). As described previously, we confirmed that the mitochondrial chap-
eronmortalin interacts with RelA and is required for RelAmitochondrial localisation (Figure 2C) [23]. Mortalin aids
the import of a subset of mitochondrial proteins by binding to them in the cytosol and facilitating their docking to
the OMM translocase [51,52]. The OMM component TOM40 was also required for mitochondrial RelA localisation
(Figures 1D and 2A). A proportion of RelA was also found in the mitoplast (Figure 1D). This biochemical evidence is
consistent with previous ChIP data demonstrating that RelA can alter mitochondrial metabolism by associating with
mtDNA indirectly [23]. In contrast, IκBα was not found in the mitoplast, suggesting it functions differently to RelA,
perhaps in preventing apoptosis as previously shown [27].
Intriguingly, we identified hypoxia as a novel stimulus resulting in rapid and transient accumulation of RelA and
IκBα into mitochondria, independently of HIF1α accumulation and Ca2+ release (Figures 3 and 4). STAT3 also
accumulated rapidly in mitochondria following hypoxia (Figure 5B,C). STAT3 mitochondrial import is well defined.
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Figure 4. Mitochondrial translocation of RelA and IκBα during hypoxia is dependent on ROS
(A) Cytosolic and mitochondrial extracts were prepared by differential centrifugation from MDA-MB-231 cells treated with 1 mM of
the hypoxia mimetic DMOG for 1 and 4 h (B). MCF7 cells were treated with 5 μM Thapsigargin (C) or 10 mMNAC for 1h (D) and then
exposed to 1% O2 for 30 min before mitochondria and cytosolic fractions were isolated. All mitochondrial fractions were treated
with 10 ng/μg of protein with proteinase K for 30 min on ice. Protein levels in each fraction were assessed by immunoblotting as
indicated. Data are representative of a minimum of two independent experiments.
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Figure 5. Inhibition of NF-κB or STAT3 signalling impairs hypoxia dependent RelA and IκBα mitochondrial translocation
PC3 cells were treated with 10 μM TPCA1 (A) or MCF7 cells were treated with 20 μM STATTIC (B) then exposed to 1% O2 for 30
min. Cytosolic and mitochondrial extracts were prepared by differential centrifugation and mitochondrial fractions were incubated
with 10 ng/μg of protein with proteinase K for 30 min on ice. (C) Hypoxia- and NAC-treated extracts from Figure 3D were analysed
by immunoblotting for STAT3 levels. Data are representative of a minimum of two independent experiments.
Similarly to RelA, STAT3 also uses a chaperone for import as well as for integration into complex I within the IMM
[53]. Furthermore, Ser727 phosphorylation andK87 acetylation of STAT3 are crucial formitochondrial import [53,54].
Inhibition of NF-κB and STAT3 signalling, with TPCA1 and STATTIC, respectively, reduced mitochondrial RelA
and IκBα during hypoxia (Figure 5). STATTIC and TPCA1 can both prevent Ser727 phosphorylation of STAT3
[47,49,50], thereby, inhibiting STAT3 mitochondrial localisation simply by reducing mitochondrial import. STAT-
TIC has also been found to reduce NF-κB activation and DNA binding, presumably due to crosstalk with STAT3
signalling [50,55]. A direct inhibitory effect of STATTIC on NF-κB, however, cannot be excluded.
STATTIC treatment also leads to increased mitochondrial ROS production and opening of the mitochondrial per-
meability transition pore (MPTP), a conductance channel at the IMM that leads tomitochondrial swelling, rupture of
the OMM and apoptosis [56,57]. We therefore can also not rule out that reduction of RelA and IκBαmitochondrial
10 © 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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levels after STATTIC treatment might be due to loss of the integrity of the mitochondrial membranes and consequent
leakage of mitochondrial proteins.
Mitochondrial STAT3 regulates mitochondrial complex I and complex II activity [58,59]; controls pyruvate to
acetyl-CoA conversion, ATP production, fatty acid synthesis and themitochondrial potential following insulin stimu-
lation [54]. It also suppressesmitochondrial ROSproduction, preventingMPTPopening and apoptosis [56–58,60,61].
It is therefore likely that during hypoxia STAT3might play a similar role in suppressing ROS production and apoptosis
(Figure 5C).
Mitochondrial ROS generated during hypoxia can activate the redox sensing tyrosine kinase c-SRC which in turn
can stimulate both NF-κB and STAT3 through tyrosine phosphorylation on IκBα and STAT3 [37,62]. Interestingly,
the kinetics of rapid ROS accumulation observed in the literature [39,45] mirror the kinetics of RelA and IκBα ac-
cumulation following exposure to hypoxia (Figure 3A). Consistent with ROS being implicated in activation of these
pathways, we observed that the antioxidant NAC reduced mitochondrial RelA, IκBα and STAT3 during hypoxia
(Figures 4C and 5C).
Similar to STAT3, IκBα has also been implicated in preventing apoptosis [27]. Inhibition of NF-kB signalling
following hypoxia in ex vivo cultured rat ventricular myocytes leads to mitochondrial potential loss, MPTP opening
and caspase 9 activation, suggestion that the anti-apoptotic role of NF-κB ismediated through themitochondria [63].
Taken together our data and the available literature point to a scenario inwhichmitochondrial RelA, IκBα and STAT3
cooperatively participate in preventing apoptosis during the early stages of hypoxia.
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